{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T22:17:37Z","timestamp":1787091457851,"version":"build-2736575974"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100023673","name":"Deanship of Scientific Research, Imam Mohammed Ibn Saud Islamic University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023673","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008840","name":"Imam Muhammad Ibn Saud Islamic University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008840","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002713","name":"Imam Mohammed Ibn Saud Islamic University","doi-asserted-by":"publisher","award":["IMSIU-DDRSP2501"],"award-info":[{"award-number":["IMSIU-DDRSP2501"]}],"id":[{"id":"10.13039\/501100002713","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bioorg.2025.109288","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T16:01:22Z","timestamp":1763827282000},"page":"109288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Nanogel delivered benzimidazole-triazole hybrids as potent multitarget inhibitors of topoisomerase and tubulin in triple-negative breast cancer"],"prefix":"10.1016","volume":"167","author":[{"given":"Sara A.","family":"Almadani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.M.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moataz A.","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Abdur-Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamdi","family":"Bendif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walid","family":"Elfalleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waad A.","family":"Samman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raed","family":"Alghamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed R.","family":"Aouad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdi E.A.","family":"Zaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sobhi M.","family":"Gomha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hany E.A.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.bioorg.2025.109288_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13174287","article-title":"Breast Cancer-epidemiology, risk factors, classification, prognostic markers, and current treatment strategies-an updated review","volume":"13","author":"\u0141ukasiewicz","year":"2021","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.bioorg.2025.109288_bb0010","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11864-015-0334-8","article-title":"Breast cancer under age 40: a different approach","volume":"16","author":"Ribnikar","year":"2015","journal-title":"Curr. Treat. Options in Oncol."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109288_bb0015","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.gendis.2022.02.007","article-title":"Cancer chemotherapy and beyond: current status, drug candidates, associated risks and progress in targeted therapeutics","volume":"10","author":"Anand","year":"2023","journal-title":"Genes & diseases"},{"issue":"5","key":"10.1016\/j.bioorg.2025.109288_bb0020","first-page":"364","article-title":"Phytoconstituents as emerging therapeutics for breast cancer: mechanistic insights and clinical implications, Cancer Pathogenesis and","volume":"4","author":"Devaraji","year":"2025","journal-title":"Therapy"},{"key":"10.1016\/j.bioorg.2025.109288_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2025.102645","article-title":"Nanogels: a chemically versatile drug delivery platform","volume":"61","author":"Blagojevic","year":"2025","journal-title":"Nano Today"},{"key":"10.1016\/j.bioorg.2025.109288_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.874510","article-title":"Nanogels as target drug delivery systems in cancer therapy: a review of the last decade","volume":"13","author":"Attama","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109288_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12030290","article-title":"Nanogel: a versatile Nano-delivery system for biomedical applications","volume":"12","author":"Yin","year":"2020","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.bioorg.2025.109288_bb0040","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/wnan.1343","article-title":"Targeted nanoparticles for image-guided treatment of triple-negative breast cancer: clinical significance and technological advances","volume":"7","author":"Miller-Kleinhenz","year":"2015","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109288_bb0045","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1080\/21691401.2016.1228658","article-title":"An update on applications of nanostructured drug delivery systems in cancer therapy: a review","volume":"45","author":"Aberoumandi","year":"2017","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.bioorg.2025.109288_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.674786","article-title":"The potential application of magnetic nanoparticles for liver fibrosis Theranostics","volume":"9","author":"Eftekhari","year":"2021","journal-title":"Front. Chem."},{"key":"10.1016\/j.bioorg.2025.109288_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111053","article-title":"An analytical study of Trastuzumab-dendrimer-fluorine drug delivery system in breast cancer therapy in vitro","volume":"133","author":"Bartusik-Aebisher","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2025.109288_bb0060","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.jddst.2019.05.024","article-title":"Advanced drug delivery system with nanomaterials for personalised medicine to treat breast cancer","volume":"52","author":"Han","year":"2019","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.bioorg.2025.109288_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2021.110398","article-title":"Synthesis of pH-sensitive nanocarriers based on polyacrylamide grafted nanocrystalline cellulose for targeted drug delivery to folate receptor in breast cancer cells","volume":"150","author":"Ehsanimehr","year":"2021","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.bioorg.2025.109288_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119122","article-title":"Facile strategy by hyaluronic acid functional carbon dot-doxorubicin nanoparticles for CD44 targeted drug delivery and enhanced breast cancer therapy","volume":"578","author":"Li","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"19","key":"10.1016\/j.bioorg.2025.109288_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26195905","article-title":"Controlled drug delivery systems: Current status and future directions","volume":"26","author":"Adepu","year":"2021","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"4","key":"10.1016\/j.bioorg.2025.109288_bb0080","doi-asserted-by":"crossref","DOI":"10.1088\/1748-605X\/abe5fa","article-title":"Biocompatibility of nanomaterials and their immunological properties","volume":"16","author":"Kyriakides","year":"2021","journal-title":"Biomedical materials (Bristol, England)"},{"key":"10.1016\/j.bioorg.2025.109288_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2019.05.018","article-title":"Stimulus-responsive polymeric nanogels as smart drug delivery systems","volume":"92","author":"Hajebi","year":"2019","journal-title":"Acta Biomater."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109288_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/md21040211","article-title":"Chitosan nanoparticles-based Cancer drug delivery: application and challenges","volume":"21","author":"Sachdeva","year":"2023","journal-title":"Mar. Drugs"},{"issue":"10","key":"10.1016\/j.bioorg.2025.109288_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15102508","article-title":"Polysaccharide-based Nanogels to overcome mucus, skin, cornea, and blood-brain barriers: a review","volume":"15","author":"Wang","year":"2023","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109288_bb0100","first-page":"1239661","article-title":"Chitosan and its derivative-based nanoparticles in gastrointestinal cancers: molecular mechanisms of action and promising anticancer","volume":"2024","author":"Shokati Eshkiki","year":"2024","journal-title":"Strategies"},{"key":"10.1016\/j.bioorg.2025.109288_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.prmcm.2022.100116","article-title":"Salar, in vitro anticancer activity of curcumin loaded chitosan nanoparticles (CLCNPs) against Vero cells","volume":"3","author":"Deepika","year":"2022","journal-title":"Pharmacological Research - Modern Chinese Medicine"},{"issue":"15","key":"10.1016\/j.bioorg.2025.109288_bb0110","article-title":"Recent advances in synthesis and biomedical applications","volume":"14","author":"Mastella","year":"2024","journal-title":"Nanomaterials (Basel, Switzerland)"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109288_bb0115","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/17568919.2024.2437980","article-title":"Novel bis-benzimidazole-triazole hybrids: anticancer study, in silico approaches, and mechanistic investigation","volume":"17","author":"Soliman","year":"2025","journal-title":"Future Med. Chem."},{"issue":"15","key":"10.1016\/j.bioorg.2025.109288_bb0120","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202500813","article-title":"Novel Benzimidazole-1,2,3-Triazole hybrids: synthesis, dual antimicrobial, anticancer activity, mechanistic insights, and computational studies","volume":"10","author":"Soliman","year":"2025","journal-title":"ChemistrySelect"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109288_bb0125","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13065-018-0479-1","article-title":"Design, synthesis, ADME prediction and pharmacological evaluation of novel benzimidazole-1,2,3-triazole-sulfonamide hybrids as antimicrobial and antiproliferative agents","volume":"12","author":"Al-blewi","year":"2018","journal-title":"Chem. Cent. J."},{"key":"10.1016\/j.bioorg.2025.109288_bb0130","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.molstruc.2019.04.005","article-title":"Design, click synthesis, anticancer screening and docking studies of novel benzothiazole-1,2,3-triazoles appended with some bioactive benzofused heterocycles","volume":"1188","author":"Aouad","year":"2019","journal-title":"J. Mol. Struct."},{"issue":"42","key":"10.1016\/j.bioorg.2025.109288_bb0135","doi-asserted-by":"crossref","first-page":"36945","DOI":"10.1021\/acsomega.2c04883","article-title":"Versatile synthetic platform for 1,2,3-Triazole chemistry","volume":"7","author":"Vala","year":"2022","journal-title":"ACS Omega"},{"issue":"23","key":"10.1016\/j.bioorg.2025.109288_bb0140","doi-asserted-by":"crossref","first-page":"9858","DOI":"10.1039\/D5NJ01143D","article-title":"Discovery of potent anticancer tricarboxamide analogs linked to 1,2,3-triazole, promoting EGFR and VEGFR downregulation","volume":"49","author":"Albelwi","year":"2025","journal-title":"New J. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109288_bb0145","article-title":"Phenylpyrazolone-1,2,3-triazole hybrids as potent antiviral agents with promising SARS-CoV-2 main protease inhibition potential","volume":"16","author":"Musa","year":"2023","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"key":"10.1016\/j.bioorg.2025.109288_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.131568","article-title":"Discovery of triaromatic flexible agents bearing 1,2,3-Triazole with selective and potent anti-breast cancer activity and CDK9 inhibition supported by molecular dynamics","volume":"1249","author":"Ihmaid","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2025.109288_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105816","article-title":"Targeting the interplay between MMP-2, CA II and VEGFR-2 via new sulfonamide-tethered isomeric triazole hybrids; microwave-assisted synthesis, computational studies and evaluation","volume":"124","author":"Reda Aouad","year":"2022","journal-title":"Bioorg. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2025.109288_bb0160","article-title":"Design, synthesis and molecular docking of novel acetophenone-1,2,3-triazoles containing compounds as potent enoyl-acyl carrier protein reductase (InhA) inhibitors","volume":"15","author":"Albelwi","year":"2022","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"issue":"15","key":"10.1016\/j.bioorg.2025.109288_bb0165","doi-asserted-by":"crossref","first-page":"8796","DOI":"10.3390\/ijms23158796","article-title":"Design and synthesis of benzene homologues tethered with 1,2,4-triazole and 1,3,4-thiadiazole motifs revealing dual MCF-7\/HepG2 cytotoxic activity with prominent selectivity via histone demethylase LSD1 inhibitory effect","volume":"23","author":"Alsehli","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.bioorg.2025.109288_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23084241","article-title":"Synthesis, characterization and Nanoformulation of novel Sulfonamide-1,2,3-triazole molecular conjugates as potent Antiparasitic agents","volume":"23","author":"Aljohani","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.109288_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104835","article-title":"Design of molecular hybrids of phthalimide-triazole agents with potent selective MCF-7\/HepG2 cytotoxicity: synthesis, EGFR inhibitory effect, and metabolic stability","volume":"111","author":"Ihmaid","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109288_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22031162","article-title":"Design and synthesis of novel imidazole derivatives possessing Triazole pharmacophore with potent anticancer activity, and in silico ADMET with GSK-3\u03b2 molecular docking investigations","volume":"22","author":"Al-Blewi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109288_bb0185","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1021\/acsomega.0c04595","article-title":"Design, synthesis, molecular modeling, anticancer studies, and density functional theory calculations of 4-(1,2,4-Triazol-3-ylsulfanylmethyl)-1,2,3-triazole derivatives","volume":"6","author":"Al Sheikh Ali","year":"2021","journal-title":"ACS Omega"},{"issue":"14","key":"10.1016\/j.bioorg.2025.109288_bb0190","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1002\/slct.202100522","article-title":"Novel 1,2,3-Triazole derivatives as potential inhibitors against Covid-19 Main protease: synthesis, characterization, molecular docking and DFT studies","volume":"6","author":"Aouad","year":"2021","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bioorg.2025.109288_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104133","article-title":"Novel scaffold hopping of potent benzothiazole and isatin analogues linked to 1,2,3-triazole fragment that mimic quinazoline epidermal growth factor receptor inhibitors: synthesis, antitumor and mechanistic analyses","volume":"103","author":"Rezki","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2025.109288_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23112788","article-title":"Synthesis and anticancer screening of novel benzothiazole-piperazine-1,2,3-triazole hybrids","volume":"23","author":"Aouad","year":"2018","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"51","key":"10.1016\/j.bioorg.2025.109288_bb0205","doi-asserted-by":"crossref","first-page":"36158","DOI":"10.1039\/D3RA07714D","volume":"13","author":"Draoui","year":"2023","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2025.109288_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115695","article-title":"Metal nanoparticles and carbohydrate polymers team up to improve biomedical outcomes","volume":"168","author":"Falsafi","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2025.109288_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122353","article-title":"Smart chemistry for traceless release of anticancer therapeutics","volume":"303","author":"Prange","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioorg.2025.109288_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.132251","article-title":"Exploration of benzimidazoles as potential microtubule modulators: an insight in the synthetic and therapeutic evolution","volume":"1253","author":"Laxmikeshav","year":"2022","journal-title":"J. Mol. Struct."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109288_bb0225","doi-asserted-by":"crossref","first-page":"2166037","DOI":"10.1080\/14756366.2023.2166037","article-title":"Identification of new benzimidazole-triazole hybrids as anticancer agents: multi-target recognition, in vitro and in silico studies","volume":"38","author":"Othman","year":"2023","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109288_bb0230","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1124\/mol.105.011544","article-title":"Reactive oxygen species elicit apoptosis by concurrently disrupting topoisomerase II and DNA-dependent protein kinase","volume":"68","author":"Lu","year":"2005","journal-title":"Mol. Pharmacol."},{"issue":"7","key":"10.1016\/j.bioorg.2025.109288_bb0235","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1021\/acssensors.4c00381","article-title":"CS\/PVP hydrogel-based Nanocapillary for monitoring bacterial growth and rapid antibiotic susceptibility testing","volume":"9","author":"Cui","year":"2024","journal-title":"ACS Sens."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109288_bb0240","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2174\/0115734064313626240912063644","article-title":"Benzimidazole conjugates as multi-target anticancer agents - a comprehensive review","volume":"21","author":"Remya","year":"2025","journal-title":"Medicinal chemistry (Shariqah (United Arab Emirates))"},{"issue":"6","key":"10.1016\/j.bioorg.2025.109288_bb0245","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202200051","article-title":"Benzimidazole hybrids as anticancer drugs: an updated review on anticancer properties, structure-activity relationship, and mechanisms of action (2019-2021)","volume":"355","author":"Feng","year":"2022","journal-title":"Arch. Pharm."},{"issue":"43","key":"10.1016\/j.bioorg.2025.109288_bb0250","doi-asserted-by":"crossref","first-page":"35941","DOI":"10.1039\/D5RA05150A","article-title":"Development of carboximidamide small molecule nanogels as potent antimicrobial functional drug delivery systems","volume":"15","author":"Almohaywi","year":"2025","journal-title":"RSC Adv."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109288_bb0255","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1080\/14756366.2021.2017911","article-title":"Synthesis, biological evaluation, and molecular docking of new series of antitumor and apoptosis inducers designed as VEGFR-2 inhibitors","volume":"37","author":"Abdallah","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109288_bb0260","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.molstruc.2019.03.012","article-title":"Developing lipophilic aromatic halogenated fused systems with specific ring orientations, leading to potent anticancer analogs and targeting the c-Src kinase enzyme","volume":"1186","author":"Ahmed","year":"2019","journal-title":"J. Mol. Struct."},{"issue":"07","key":"10.1016\/j.bioorg.2025.109288_bb0265","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1142\/S2737416522300036","article-title":"Extensive study of DFT-quantum calculations based QSAR modeling of fused 1,2,4-triazine derivatives revealed potent CYP1A1 inhibitors","volume":"21","author":"Ahmed","year":"2022","journal-title":"Journal of Computational Biophysics and Chemistry"},{"key":"10.1016\/j.bioorg.2025.109288_bb0270","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.molstruc.2019.03.012","article-title":"Developing lipophilic aromatic halogenated fused systems with specific ring orientations, leading to potent anticancer analogs and targeting the c-Src kinase enzyme","volume":"1186","author":"Ahmed","year":"2019","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2025.109288_bb0275","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.bioorg.2017.11.019","article-title":"Design, synthesis, molecular docking of new lipophilic acetamide derivatives affording potential anticancer and antimicrobial agents","volume":"76","author":"Ahmed","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109288_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154854","article-title":"The pathophysiology of the cell cycle in cancer and treatment strategies using various cell cycle checkpoint inhibitors","volume":"251","author":"Almalki","year":"2023","journal-title":"Pathol. Res. Pract."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109288_bb0285","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/09674845.2004.11732652","article-title":"Links between apoptosis, proliferation and the cell cycle","volume":"61","author":"Alenzi","year":"2004","journal-title":"Br. J. Biomed. Sci."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109288_bb0290","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10616-012-9481-y","article-title":"Beyond annexin V: fluorescence response of cellular membranes to apoptosis","volume":"65","author":"Demchenko","year":"2013","journal-title":"Cytotechnology"},{"key":"10.1016\/j.bioorg.2025.109288_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.102988","article-title":"3D-QSAR pharmacophore modelling, virtual screening and docking studies for lead discovery of a novel scaffold for VEGFR 2 inhibitors: design, synthesis and biological evaluation","volume":"89","author":"Sobhy","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"1\u20132","key":"10.1016\/j.bioorg.2025.109288_bb0300","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"issue":"7","key":"10.1016\/j.bioorg.2025.109288_bb0305","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1021\/np020725b","volume":"65","author":"Demirci","year":"2002","journal-title":"J. Nat. Prod."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109288_bb0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R","article-title":"Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure","volume":"31","author":"van Engeland","year":"1998","journal-title":"Cytometry"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109288_bb0315","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0022-1759(95)00072-I","article-title":"A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V","volume":"184","author":"Vermes","year":"1995","journal-title":"J. Immunol. Methods"},{"issue":"3","key":"10.1016\/j.bioorg.2025.109288_bb0320","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/nprot.2013.011","article-title":"Merging high-quality biochemical fractionation with a refined flow cytometry approach to monitor nucleocytoplasmic protein expression throughout the unperturbed mammalian cell cycle","volume":"8","author":"Rosner","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bioorg.2025.109288_bb0325","series-title":"Topoisomerase assays, Current protocols in pharmacology Chapter 3","author":"Nitiss","year":"2012"},{"issue":"10","key":"10.1016\/j.bioorg.2025.109288_bb0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007238","article-title":"Identification of a novel topoisomerase inhibitor effective in cells overexpressing drug efflux transporters","volume":"4","author":"Fayad","year":"2009","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/j.bioorg.2025.109288_bb0335","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","article-title":"Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function","volume":"19","author":"Morris","year":"1998","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2025.109288_bb0340","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-2269-7_19","article-title":"Small-molecule library screening by docking with PyRx","volume":"1263","author":"Dallakyan","year":"2015","journal-title":"Methods. Mol. Biol. (Clifton, N.J.)"},{"issue":"6","key":"10.1016\/j.bioorg.2025.109288_bb0355","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1103\/PhysRevA.38.3098","article-title":"Density-functional exchange-energy approximation with correct asymptotic behavior","volume":"38","author":"Becke","year":"1988","journal-title":"Phys. Rev. A"}],"updated-by":[{"DOI":"10.1016\/j.bioorg.2025.109318","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T00:00:00Z","timestamp":1764979200000}},{"DOI":"10.1016\/j.bioorg.2025.109318","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000}}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682501168X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682501168X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T17:39:21Z","timestamp":1768671561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004520682501168X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":69,"alternative-id":["S004520682501168X"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109288","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanogel delivered benzimidazole-triazole hybrids as potent multitarget inhibitors of topoisomerase and tubulin in triple-negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109288","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109288"}}